Literature DB >> 17703254

The role of enhanced external counterpulsation in the treatment of angina and heart failure.

Rohit R Arora1, Ankur G Shah.   

Abstract

As the incidence of angina and heart failure continue to rise, new therapeutic options will be needed to treat patients who remain symptomatic or who are intolerant to current treatment. Enhanced external counterpulsation (EECP) is a noninvasive modality being investigated in both angina and congestive heart failure patients. It has been proven to provide symptomatic benefit in angina patients, but has not been proven to show an increase in life expectancy or decrease in cardiovascular events. EECP in heart failure has been proven to be safe, but its efficacy is still uncertain. The present paper summarizes the current literature on the clinical use of EECP in angina and heart failure.

Entities:  

Mesh：

Year:  2007        PMID： 17703254      PMCID： PMC2651381          DOI： 10.1016/s0828-282x(07)70826-7

Source DB:  PubMed          Journal:  Can J Cardiol        ISSN： 0828-282X            Impact factor:   5.223


  24 in total

1.  Comparison of hemodynamic effects of enhanced external counterpulsation and intra-aortic balloon pumping in patients with acute myocardial infarction.

Authors:  I Taguchi; K Ogawa; A Oida; S Abe; N Kaneko; H Sakio
Journal:  Am J Cardiol       Date:  2000-11-15       Impact factor: 2.778

2.  Two-year clinical outcomes after enhanced external counterpulsation (EECP) therapy in patients with refractory angina pectoris and left ventricular dysfunction (report from The International EECP Patient Registry).

Authors:  Ozlem Soran; Elizabeth D Kennard; Abdallah Georges Kfoury; Sheryl F Kelsey
Journal:  Am J Cardiol       Date:  2005-11-02       Impact factor: 2.778

3.  Can angiographic findings predict which coronary patients will benefit from enhanced external counterpulsation?

Authors:  W E Lawson; J C Hui; Z S Zheng; L Burger; L Jiang; O Lillis; H S Soroff; P F Cohn
Journal:  Am J Cardiol       Date:  1996-05-15       Impact factor: 2.778

4.  Improved exercise tolerance following enhanced external counterpulsation: cardiac or peripheral effect?

Authors:  W E Lawson; J C Hui; Z S Zheng; L Burgen; L Jiang; O Lillis; Z Oster; H Soroff; P Cohn
Journal:  Cardiology       Date:  1996 Jul-Aug       Impact factor: 1.869

5.  Predictors of benefit in angina patients one year after completing enhanced external counterpulsation: initial responders to treatment versus nonresponders.

Authors:  William E Lawson; John C K Hui; Elizabeth D Kennard; Gregory Barsness; Sheryl F Kelsey
Journal:  Cardiology       Date:  2005-04-13       Impact factor: 1.869

6.  Effects of enhanced external counterpulsation on Health-Related Quality of Life continue 12 months after treatment: a substudy of the Multicenter Study of Enhanced External Counterpulsation.

Authors:  Rohit R Arora; Tony M Chou; Diwakar Jain; Bruce Fleishman; Lawrence Crawford; Thomas McKiernan; Richard Nesto; Carol Estwing Ferrans; Susan Keller
Journal:  J Investig Med       Date:  2002-01       Impact factor: 2.895

7.  Frequency and efficacy of repeat enhanced external counterpulsation for stable angina pectoris (from the International EECP Patient Registry).

Authors:  Andrew D Michaels; Gregory W Barsness; Ozlem Soran; Sheryl F Kelsey; Elizabeth D Kennard; John C K Hui; William E Lawson
Journal:  Am J Cardiol       Date:  2005-02-01       Impact factor: 2.778

8.  Prior revascularization increases the effectiveness of enhanced external counterpulsation.

Authors:  W E Lawson; J C Hui; T Guo; L Burger; P F Cohn
Journal:  Clin Cardiol       Date:  1998-11       Impact factor: 2.882

9.  Anti-ischemic effects and long-term survival during ranolazine monotherapy in patients with chronic severe angina.

Authors:  Bernard R Chaitman; Sandra L Skettino; John O Parker; Peter Hanley; Jaroslav Meluzin; Jerzy Kuch; Carl J Pepine; Whedy Wang; Jeanenne J Nelson; David A Hebert; Andrew A Wolff
Journal:  J Am Coll Cardiol       Date:  2004-04-21       Impact factor: 24.094

10.  Enhanced external counterpulsation improves endothelial function in patients with symptomatic coronary artery disease.

Authors:  Piero O Bonetti; Gregory W Barsness; Paul C Keelan; Theresa I Schnell; Geralyn M Pumper; Jeffrey T Kuvin; Robert P Schnall; David R Holmes; Stuart T Higano; Amir Lerman
Journal:  J Am Coll Cardiol       Date:  2003-05-21       Impact factor: 24.094
View more
  2 in total

1.  Electrical myostimulation improves left ventricular function and peak oxygen consumption in patients with chronic heart failure: results from the exEMS study comparing different stimulation strategies.

Authors:  Frank van Buuren; Klaus Peter Mellwig; Christian Prinz; Britta Körber; Andreas Fründ; Dirk Fritzsche; Lothar Faber; Tanja Kottmann; Nicola Bogunovic; Johannes Dahm; Dieter Horstkotte
Journal:  Clin Res Cardiol       Date:  2013-04-12       Impact factor: 5.460

Review 2.  Enhanced external counterpulsation: A unique treatment for the "No-Option" refractory angina patient.

Authors:  Jose Caceres; Patricia Atal; Rohit Arora; Derek Yee
Journal:  J Clin Pharm Ther       Date:  2021-01-07       Impact factor: 2.512
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.